MedPath

ack of Empathy as a Symptom in various Psychiatric Disorders - Psychopathology and the Lack of Empathy

Phase 1
Conditions
Autism Spectrum Disorder (Autism, Asperger's Syndrome)Conduct DisorderMild Mental Retardation
MedDRA version: 9.1Level: LLTClassification code 10003805Term: Autism
MedDRA version: 9.1Level: LLTClassification code 10064478Term: Conduct disorder
MedDRA version: 9.1Level: LLTClassification code 10027618Term: Mild mental retardation
Registration Number
EUCTR2009-009475-35-NL
Lead Sponsor
KARAKTER universitair centrum voor kinder- en jeudpsychiatrie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

Boys, aged 12 to 19 years, with an average intelligence (Total IQ = 85; according to DSM-IV-TR), and with a diagnosis of Autism of Conduct Disorder. Subjects need to meet criteria according to the DISC-IV computer version. This is a structured questionnaire, which has to be filled in by parents, and which aims at psychopathology according to DSM-IV-TR criteria
Are the trial subjects under 18? yes
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Youth using medication which can influence facial expression (i.e., antipsychotics and certain antidepressants) and temporary discontinuation of medication is contraindicated (i.e., psychotic disorder, severe major depression) will be excluded.
Whether discontinuation is appropriate will be decided by mutual agreement with the subject, the psychiatrist treating the subject, and if necessary, parents of the subject. If so, discontinuation will last for at least 5 times half-life of the medication used, and will be continued the day after participation in the investigation.
Furthermore, youth with prominent comorbidity which could influence neurologic or neurocognitive functioning, such as:
• schizofrenia, psychotic disorder
• bipolar disorder
• substance abuse of dependency
• tics
• language disorder
• epilepsy

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath